|
Name |
Cytochalasin e
|
Molecular Formula | C28H33NO7 | |
IUPAC Name* |
(1S,5E,7R,9S,11E,13S,14S,16R,17S,18S,19S)-19-benzyl-7-hydroxy-7,9,16,17-tetramethyl-2,4,15-trioxa-20-azatetracyclo[11.8.0.01,18.014,16]henicosa-5,11-diene-3,8,21-trione
|
|
SMILES |
C[C@H]1C/C=C/[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@]2(C(=O)N[C@H]4CC5=CC=CC=C5)OC(=O)O/C=C/[C@@](C1=O)(C)O)C)C
|
|
InChI |
InChI=1S/C28H33NO7/c1-16-9-8-12-19-23-27(4,35-23)17(2)21-20(15-18-10-6-5-7-11-18)29-24(31)28(19,21)36-25(32)34-14-13-26(3,33)22(16)30/h5-8,10-14,16-17,19-21,23,33H,9,15H2,1-4H3,(H,29,31)/b12-8+,14-13+/t16-,17-,19-,20-,21-,23-,26+,27+,28+/m0/s1
|
|
InChIKey |
LAJXCUNOQSHRJO-ZYGJITOWSA-N
|
|
Synonyms |
cytochalasin e; 36011-19-5; Cytochalasin E from Aspergillus clavatus; CHEBI:68201; CYTOCHALASINE; NSC175151; HSDB 3548; NSC-175151; 21,23-Dioxa(13)cytochalasa-13,19-diene-1,17,22-trione, 6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18R,19E)-; EINECS 252-835-7; MFCD00005178; NSC 175151; SCHEMBL33617; CHEMBL494856; DTXSID60894866; HY-N6772; Cytochalasin E, Aspergillus clavatus; CCG-39859; ZINC42805205; NCGC00380287-01; 6,7-Epoxy-10-phenyl-5,6,16,18-tetramethyl-21,23-dioxa-(13)cytochalas-13,19-diene-17,22-dione; CS-0093424; Q5201338; 21,19-diene-1,17,22-trione, 6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18R,19E)-
|
|
CAS | 36011-19-5 | |
PubChem CID | 5458385 | |
ChEMBL ID | CHEMBL494856 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 495.6 | ALogp: | 3.5 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 115.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 36 | QED Weighted: | 0.364 |
Caco-2 Permeability: | -4.662 | MDCK Permeability: | 0.00004550 |
Pgp-inhibitor: | 0.198 | Pgp-substrate: | 0.191 |
Human Intestinal Absorption (HIA): | 0.027 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.873 |
Blood-Brain-Barrier Penetration (BBB): | 0.839 | Plasma Protein Binding (PPB): | 88.34% |
Volume Distribution (VD): | 0.823 | Fu: | 13.35% |
CYP1A2-inhibitor: | 0.036 | CYP1A2-substrate: | 0.216 |
CYP2C19-inhibitor: | 0.399 | CYP2C19-substrate: | 0.512 |
CYP2C9-inhibitor: | 0.151 | CYP2C9-substrate: | 0.039 |
CYP2D6-inhibitor: | 0.117 | CYP2D6-substrate: | 0.089 |
CYP3A4-inhibitor: | 0.952 | CYP3A4-substrate: | 0.646 |
Clearance (CL): | 9.391 | Half-life (T1/2): | 0.285 |
hERG Blockers: | 0.064 | Human Hepatotoxicity (H-HT): | 0.268 |
Drug-inuced Liver Injury (DILI): | 0.717 | AMES Toxicity: | 0.102 |
Rat Oral Acute Toxicity: | 0.967 | Maximum Recommended Daily Dose: | 0.638 |
Skin Sensitization: | 0.474 | Carcinogencity: | 0.545 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.018 |
Respiratory Toxicity: | 0.975 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001865 | 0.696 | D0V3ZA | 0.267 | ||||
ENC002202 | 0.683 | D01TSI | 0.260 | ||||
ENC005546 | 0.628 | D09NNH | 0.260 | ||||
ENC002419 | 0.618 | D0SP3D | 0.259 | ||||
ENC001886 | 0.602 | D0W7RJ | 0.254 | ||||
ENC002622 | 0.585 | D06CWH | 0.252 | ||||
ENC002762 | 0.563 | D0R1BD | 0.244 | ||||
ENC002828 | 0.563 | D00OAY | 0.243 | ||||
ENC004026 | 0.558 | D08UMH | 0.242 | ||||
ENC004444 | 0.543 | D0Y7RW | 0.235 |